AU Patent

AU2007311019B2 — Diclofenac gel

Assigned to Nuvo Pharmaceuticals Inc · Expires 2013-05-16 · 13y expired

What this patent protects

The present invention provides a gel formulation comprising diclofenac sodium which has superior transdermal flux properties, which may be used for the topical treatment of pain, such as in osteoarthritis.

USPTO Abstract

The present invention provides a gel formulation comprising diclofenac sodium which has superior transdermal flux properties, which may be used for the topical treatment of pain, such as in osteoarthritis.

Drugs covered by this patent

Patent Metadata

Patent number
AU2007311019B2
Jurisdiction
AU
Classification
—
Expires
2013-05-16
Drug substance claim
No
Drug product claim
No
Assignee
Nuvo Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.